Comparative Pharmacology
Head-to-head clinical analysis: PROVAL 3 versus VICKS FORMULA 44.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PROVAL 3 versus VICKS FORMULA 44.
PROVAL #3 vs VICKS FORMULA 44
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Proval #3 is a combination of acetaminophen (paracetamol), butalbital, and caffeine. Acetaminophen inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis in the CNS, raising the pain threshold. Butalbital is a barbiturate that enhances GABA-A receptor activity, producing sedation and anxiolysis. Caffeine is a CNS stimulant that potentiates analgesic effects via adenosine receptor antagonism.
VICKS FORMULA 44 contains dextromethorphan (NMDA receptor antagonist and sigma-1 receptor agonist; suppresses cough by acting on the medullary cough center) and doxylamine (first-generation antihistamine; H1-receptor antagonist; anticholinergic and sedative effects).
1-2 tablets orally every 4-6 hours as needed for pain; not to exceed 8 tablets per day.
VICKS FORMULA 44 is a combination product containing dextromethorphan (cough suppressant) and doxylamine (antihistamine). The typical adult dose is 30 mg dextromethorphan/6.25 mg doxylamine (15 mL) orally every 6 hours as needed for cough and cold symptoms, not to exceed 4 doses per 24 hours.
None Documented
None Documented
4–6 hours in adults with normal hepatic function; prolonged in hepatic impairment (8–12 hours).
Dextromethorphan: 3-6 hours (extensive metabolizers), up to 24 hours (poor metabolizers); doxylamine: 10-12 hours. Clinically, half-life may be prolonged in elderly, hepatic impairment, or CYP2D6 poor metabolizers.
Primarily hepatic metabolism (CYP450) with <5% excreted unchanged in urine. Biliary/fecal elimination accounts for ~15% as metabolites.
Renal excretion of unchanged drug and metabolites (dextromethorphan and doxylamine): dextromethorphan is extensively metabolized; <10% excreted unchanged. Doxylamine: ~60% excreted renally as unchanged and metabolites.
Category C
Category C
Antitussive
Antitussive